Abstract
OBJECTIVES: PLEKHM1 is an adaptor protein that regulates fusion events in the endolysosomal system that is required for growth factor receptor degradation. Low expression of PLEKHM1 has been attributed to poor survival in a variety of solid tumors. Our goal is to relate PLEKHM1 expression with prognostic variables for patients with endometrial adenocarcinomas (EA).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
